Madrigal Pharmaceuticals Inc (MDGL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -465,892 | -373,630 | -295,350 | -241,846 | -202,244 |
| Depreciation Amortization | 2,785 | 2,941 | 1,264 | 405 | 471 |
| Accounts receivable | -53,822 | 0 | 0 | N/A | N/A |
| Accounts payable and accrued liabilities | 15,558 | 4,210 | 2,451 | 20,363 | -161 |
| Other Working Capital | -72,345 | -3,276 | 37,604 | 30,651 | 23,482 |
| Other Operating Activity | 118,144 | 45,525 | 29,174 | 6,510 | 20,891 |
| Operating Cash Flow | $-455,572 | $-324,230 | $-224,857 | $-183,917 | $-157,561 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -267,924 | -501,041 | 206,903 | -4,846 | 160,114 |
| PPE Investments | -1,462 | -1,479 | -217 | -209 | -334 |
| Purchase Sale Intangibles | -5,000 | 0 | 0 | N/A | N/A |
| Other Investing Activity | -5,000 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $-274,386 | $-502,520 | $206,686 | $-5,055 | $159,780 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 0 | 65,000 | 50,000 | 1,030 | 0 |
| Common Stock Issued | 735,062 | 530,479 | 264,337 | 170,207 | 5,088 |
| Other Financing Activity | 0 | -363 | -886 | 0 | 0 |
| Financing Cash Flow | $735,062 | $595,116 | $313,451 | $171,237 | $5,088 |
| Beginning Cash Position | 99,915 | 331,549 | 36,269 | 54,004 | 46,697 |
| End Cash Position | 105,019 | 99,915 | 331,549 | 36,269 | 54,004 |
| Net Cash Flow | $5,104 | $-231,634 | $295,280 | $-17,735 | $7,307 |
| Free Cash Flow | |||||
| Operating Cash Flow | -455,572 | -324,230 | -224,857 | -183,917 | -157,561 |
| Capital Expenditure | -1,462 | -1,479 | -217 | -209 | -334 |
| Free Cash Flow | -457,034 | -325,709 | -225,074 | -184,126 | -157,895 |